Jacquelyn Fahey Sandell is the Chief Legal Officer at Voyager Therapeutics Inc., a position she has held since joining the company. With a robust background in the legal aspects of the biotechnology and pharmaceutical industries, Sandell has become an integral part of Voyager's leadership team. Prior to her current role, she held significant positions at several notable organizations, including serving as the general counsel at a leading biopharma company. Her expertise in navigating complex regulatory environments and her strategic legal guidance have been pivotal in advancing Voyager's mission to develop innovative gene therapies for severe neurological diseases. At Voyager Therapeutics, Sandell oversees all legal affairs, ensuring compliance with industry regulations and safeguarding the company's intellectual property. Her role is crucial in steering the company through the intricate landscape of drug development and commercialization. Under her leadership, Voyager has successfully advanced several gene therapy programs through clinical trials, a testament to her ability to manage legal challenges while fostering innovation. Sandell's strategic vision and legal acumen have been instrumental in securing partnerships and collaborations that have propelled the company forward. In addition to her professional achievements, Sandell is recognized for her contributions to the broader biotech community. She frequently speaks at industry conferences and participates in panels discussing the legal and ethical considerations of gene therapy. Her commitment to mentoring young professionals in the field further underscores her dedication to advancing the industry. Sandell's comprehensive understanding of both the legal and scientific aspects of biotechnology makes her a valuable asset to Voyager Therapeutics and a respected figure in the sector.